WilliamFrancisOwenJr.MDAAHIVMS

Internal Medicine • San Francisco, CA

HIV/AIDS Medicine

Private Practice, William F. Owen, Jr., M.D.

Join to view full profile

Dr. Owen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Owen's full profile

Already have an account?

Office
77 Van Ness Ave
Ste 101
San Francisco, CA 94102
Phone+1 415-867-4252

Fax+1 888-960-2124
Is this information wrong?

Summary

William F. Owen Jr, MD, was in private practice in internal medicine and HIV Medicine in San Francisco’s Mission and Castro Districts from October 1979 through December 2014. He was a physician at Sutter Pacific Medical Foundation from January 2015 through January 2017. He also served as an active staff member at CPMC and its component hospitals from 1979 through January 2017. He retired as of February 2017.

Dr. Owen received both his undergraduate and medical degree from Temple University. His postgraduate training included a residency at Baystate Medical Center/Tufts University in Springfield, Massachusetts. He also completed a fellowship in emergency medicine at University of California, San Francisco. He is certified by the American Board of Internal Medicine and is credentialed as an HIV specialist by the American Academy of HIV Medicine.

Dr. Owen wrote one of the first review articles about health care issues of gay men that was published in the Annals of Internal Medicine in 1980 and has been an author of numerous other articles in the areas of gay health care and HIV Medicine. He was a founder, in 1977, of Bay Area Physicians for Human Rights (BAPHR), one of the first organizations of gay doctors in the U.S. His honors include the American Society of Internal Medicine Special Recognition Award and the naming of The Owen Clinic at the University of California, San Diego in recognition of his work with gay patients. In January 2019, he was presented with a lifetime Community Service Award by the Global HIV/AIDS program at Zuckerberg San Francisco General Hospital.

ZSFGH Community Service Award to Bill Owen MD (full) - 16 January 2019

Bill Owen MD receives ZSFGH Global HIV Community Service Tribute - Full Award Ceremony - 1/16/2019

Education & Training

Health1976 - 1978
UMass ChanResidency, Internal Medicine, 1973 - 1976
Lewis Katz School of Medicine at Temple UniversityClass of 1973
Temple UniversityBA, Cum laude, 1969

Certifications & Licensure

CA State Medical License 1976 - 2025
American Board of Internal Medicine Internal Medicine
American Academy of HIV MedicineDiplomate

Awards, Honors, & Recognition

HIV Community Service Award Zuckerberg San Francisco General Global AIDS, 2019
CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013
Top-rated primary care physicians in the San Francisco Bay Area Bay Area Consumer Checkbook, 2006
One of the top primary care physicians in the San Francisco Bay Area San Francisco Magazine, 2005
One of the best HIV/AIDS doctors in the San Francisco Bay Area San Francisco Magazine, 2004
Annual Gay Pride Community Service Award San Francisco PBS affiliate KQED, 2000
Special Recognition Award The American Society of Internal Medicine, 1988
Join now to see all

Publications & Presentations

Journal Articles

The Strategies for Management of Antiretroviral Therapy (SMART) Study Group CD4+ Count-Guided Interruption of Antiretroviral Treatment.
Owen Jr, WE, N Engl J Med 355(22):2283-96
Sexually transmitted diseases and traumatic problems in homosexual men.
Owen WF Jr., Ann Intern Med 92(6):805-8
The clinical approach to the homosexual patient.
Owen WF Jr., Ann Intern Med 93(1):90-2
Medical aspects of homosexuality.
McGhee RD, Owen WF Jr., N Engl J Med 303(1):50-1
Hepatitis B and sexual practices.
Bolan RK, Owen WF Jr, Owen RL, Ann Intern Med 96(5):678
Sexually transmitted diseases in the homosexual community.
Owen WF Jr., Dermatol Clin North Am 1(1):123-9
Medical problems of the homosexual adolescent.
Owen WF Jr., J Adolesc Health Care 6(4):278-85
The clinical approach to the male homosexual patient.
Owen WF Jr., Med Clin North Am 70(3):499-535.
Trauma and other noninfectious problems in homosexual men.
Bush RA Jr, Owen WF Jr, Med Clin North Am 70(3):549-66
Trauma and other noninfectious problems in homosexual men.
Bush RA Jr, Owen WF Jr, Med Clin North Am 70(3):549-66
Preventing transmission of human immunodeficiency virus infection.
Owen WF Jr., West J Med 148(2):198
Granulomatous pulmonary lesions in patients with the acquired immunodeficiency syndrome (AIDS) and Pneumocystis carinii infection.
Blumenfeld W, Basgoz N, Owen WF Jr, Schmidt DM, Ann Intern Med 109(6):505-7
Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection.
Drew WL, Miner RC, Busch DF, Follansbee SE, Gullett J, Mehalko SG, Gordon SM, Owen WF Jr, Matthews Tr, Buhles WC, et al., J Infect Dis 163(4):716-719
Mononeuritis multiplex associated with cryoglobulinemia in HIV infection.
Stricker RB, Sanders KA, Owen WF, Kiprov DD, Miller RG, Neurology 42(11):2103-2105
Tolerability of combined ganciclovir and didanosine for the treatment of cytomegalovirus disease associated with AIDS.
Jacobson MA, Owen W, Campbell J, Brosgart C, Abrams DI, Clin Infect Dis 16 Suppl 1():S69-73
Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir resistant mucocutaneous infection with herpes simplex virus in a patient...
Lalezari JP, Drew WL, Glutzer E, Miner D, Safrin S, Owen WF Jr, Davidson JM, Fisher PE, Jaffe HS, J Infect Dis 170(3):570-572
Join now to see all

Books/Book Chapters

Textbook of Homosexuality and Mental Health.
Chapter: Gay and bisexual men and medical care
Page 673 - 686Owen WF Jr.Editors: Cabaj RP, Stein TS.American Psychiatric Press, Inc, Washington, D.C
Clinics in Podiatric Medicine and Surgery.
Chapter: Antiretroviral therapies
Page 227 - 239Owen WF Jr.Editors: Tinkle JD.W.B. Saunders, Philadelphia
Practical Care of the Ambulatory Patient.
Chapter: Medical evaluation of the gay male patient
Page 351 - 381Owen WF Jr.Editors: Stults BM, Dere WH.W.B. Saunders, Philadelphia
AIDS/HIV Experimental Treatment Directory.
Chapter: The changing nature of medicine in the era of HIV
Owen WF Jr.Editors: Abrams D, Gottlieb M, Grieco M.New York: American Foundation for AIDS Research
Join now to see all

Abstracts/Posters

Measurement of body weight and body cell mass in patients receiving highly active antiretroviral therapy (HAART).
Berger D, Bucher G, Cimoch P, Nemechek P, Owen W, Steinhart C, Sullivan-Bolyai JZ, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada
Efficacy and Durability of Delavirdine in Pharmacokinetic Enhancement of Protease Inhibitors for AIDS Patients with Extensive Antiretroviral Therapy (ART) Experience.
Owen WF Jr, Stein C, XIII International AIDS Conference, Durban, South Africa
Multi-center analysis of delavirdine as a pharmacokinetic enhancer in HIV infected adults with extensive prior HIV treatment.
Schutz MR, Owen WF, the 38th Annual Meeting of the Infectious Diseases Society of America, New Orleans, LA
Delavirdine combined with protease inhibitors: durability and efficacy for salvage therapy in AIDS.
Owen WF, Stein C, 39th Annual Meeting of the Infectious Diseases Society of America, San Francisco, CA
Safety and efficacy of antiretroviral treatment (ART) regimens containing tenofovir DF (TDF) and atazanavir/ritonavir (ATV/r) in HIV-infected adults.
Owen Jr, WF, Chamberlain L, Warren DR, Ebrahimi R, Flaherty JF, Dong BJ, 3rd International AIDS Society Conference on Pathogenesis and Treatment, Rio de Janeiro, Brazil
Safety and efficacy of antiretroviral treatment (ART) regimens containing tenofovir DF (TDF) and atazanavir/ritonavir (ATV/RTV) in HIV-infected adults.
Owen Jr, WF, Chamberlain L, Warren DR, Ebrahimi R, Dong BJ, Flaherty JF, 10th European AIDS Conference / EACS, Dublin, Ireland
Safety and efficacy of antiretroviral treatment (ART) regimens containing tenofovir DF (TDF) and atazanavir/ritonavir (ATV/r) in HIV-infected adults.
Owen W, Chamberlain L, Warren D, Ebrahimi R, Dong B, Flaherty J., 15th Annual Canadian Conference on HIV/AIDS Research, Quebec City, Canada
Join now to see all

Other

The International HIV Controllers Study: The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation
Owen Jr, WF, Science Express
http://www.sciencemag.org/content/330/6010/1551.abstract
Safety and Effectiveness of Tenofovir/Emtricitabine or Lamivudine Plus Ritonavir Boosted Atazanavir in Treatment Experienced HIV Infected Adults at Two Urban Private M...
Dong BJ, Ward DJ, Chamberlain LA, Reddy YS, Ebrahimi R, Flaherty JF, Owen WF, J Antivir Antiretrovir 4(1): 001-005
http://www.omicsonline.org/1948-5964/JAA-04-001.php?aid=3681